Post-approval studies (Phase 4)Ended earlyNCT00936663
What this trial is testing
Using Sitagliptin as a Treatment to Prevent New Onset Diabetes After Kidney Transplantation
Who this might be right for
Type 2 DiabetesEnd Stage Renal Disease
University of Nebraska 3